Peptide ResourcesMetabolic & Weight Management

    O-304

    O-304, also written as O304, is a small molecule studied for activation of AMP-activated protein kinase, or AMPK. It sits outside the peptide family.

    Preclinical studies and an early human study have explored glucose regulation and microvascular function. Research continues into metabolic and cardiovascular applications.

    O-304 at MRC Healthcare

    What Is O-304?

    O-304 is an experimental metabolic compound investigated for effects across AMPK complexes. AMPK is involved in coordinating cellular energy supply and demand.

    Its development concerns metabolic and vascular biology, rather than an established role as a general weight management treatment.

    How Does O-304 Work?

    O-304 has been studied for promoting AMPK activation and glucose uptake and utilisation. Later preclinical work also described mitochondrial uncoupling, a process that changes the relationship between fuel use and cellular energy production.

    These findings indicate a complex mechanism. Activating an energy-related pathway does not by itself establish clinical benefit or cardiovascular safety.

    What Has Research Studied?

    A publication reported animal findings alongside a short placebo-controlled study in people with type 2 diabetes receiving metformin. Outcomes included glucose regulation and microvascular perfusion.

    Further mouse work examined muscle glucose handling and pancreatic beta-cell function, and larger, longer human studies are underway.

    Safety and Medical Supervision

    A physician reviews glucose regulation carefully, particularly when other glucose-lowering medicines are being used.

    Any consideration of use requires physician consultation and supervision within an appropriate regulated setting. A medical assessment should first address diabetes control, cardiovascular risk and approved alternatives.

    Frequently Asked Questions

    Is O-304 the same as O304?

    Yes. These spellings refer to the same compound in this context.

    Has O-304 been studied in people?

    Yes. A short early study in people with type 2 diabetes has been published, and further research is ongoing.

    Does improved microvascular perfusion prove heart protection?

    Researchers continue to study how vascular measurements relate to long-term cardiovascular health.

    Can O-304 replace prescribed diabetes medicines?

    Changes to diabetes treatment always involve the prescribing physician, who can advise how any new protocol fits with established care.

    Disclaimer

    This information, including but not limited to texts, images, graphics, labels, ingredients, indications, potential benefits, and other materials contained on this website are for informational purposes only. No part of this website is intended to be a substitute for professional medical advice, treatment, or diagnosis. Always seek the advice of your physician or other professional healthcare provider, particularly before starting a new regimen for the first time.

    Wondering Whether O-304 Is Right for You?

    Speak with our medical team about your health goals. We will help you understand which options are supported by evidence and appropriate for your situation.